Literature DB >> 1168186

Surface carbohydrates of hamster fibroblasts. II. Interaction of hamster NIL cell surfaces with Ricinus communis lectin and concanavalin A as revealed by surface galactosyl label.

C G Gahmberg, S Hakomori.   

Abstract

When hamster fibroblasts (NIL) were treated with galactose oxidase followed by reduction with tritiated borohydride (GAHMBERG, C. G. AND HAKOMORI, S. (1973) J. Biol. Chem. 248, 4311; STECK, T. L., AND DAWSON, G. (1974) J. Biol. Chem. 249, 2135), two major galactoprotein labels were detected on the cell surface: "galactoprotein a" (apparent molecular weight 200,000) and "galactoprotein b" (apparent molecular weight 130,000). The labeling in galactoprotein a of NIL cells was greatly suppressed by pretreating cells with a high concentration of Ricinus communis lectin or concanavalin A, whereas the label in it was greatly enhanced with a low concentration of the lectins. The label in galactoprotein b of NIL cells was less affected by pretreatment with lectins. In NILpy cells the label in galactoprotein a was absent and the lable in galactoprotein b was enhanced by pretreating cells with lectins at low concentrations, but it was suppressed at high concentrations. The results indicate that NIL cells mainly interact with the lectins through galactoprotein a, whereas NILpy cells interact with the lectins through galacto-protein b. After treatment with lectins, the glycolipids of normal NIL cells, but not NILpy cells, became exposed as evidenced by enhanced labeling, possibly because of "clustering" of glyco-proteins. These results support the view that specific, well defined glycoproteins are the binding sites for lectins, and that these interacting glycoproteins are qualitatively different in normal and transformed cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1168186

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Effect of concanavalin A on expression of cell surface sialyltransferase activity of mouse thymocytes.

Authors:  R G Painter; A White
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

Review 2.  [Biology of lectins and their application in clinical biochemistry (author's transl)].

Authors:  E Köttgen
Journal:  Klin Wochenschr       Date:  1977-04-15

Review 3.  Fibronectin: a review of its structure and biological activity.

Authors:  E Pearlstein; L I Gold; A Garcia-Pardo
Journal:  Mol Cell Biochem       Date:  1980-02-08       Impact factor: 3.396

4.  Demonstration of five major glycoproteins in myelin and myelin subfractions.

Authors:  E E Mena; B W Moore; S Hagen; H C Agrawal
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

5.  Possible role of ceramide in defining structure and function of membrane glycolipids.

Authors:  R Kannagi; E Nudelman; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

Review 6.  Structure and function of glycosphingolipids and sphingolipids: recollections and future trends.

Authors:  Sen-itiroh Hakomori
Journal:  Biochim Biophys Acta       Date:  2007-09-06

7.  Characterization of surface glycoproteins of mouse lymphoid cells.

Authors:  C G Gahmberg; P Häyry; L C Andersson
Journal:  J Cell Biol       Date:  1976-03       Impact factor: 10.539

8.  External fibronectin of cultured human fibroblasts is predominantly a matrix protein.

Authors:  K Hedman; A Vaheri; J Wartiovaara
Journal:  J Cell Biol       Date:  1978-03       Impact factor: 10.539

9.  Mobility of voltage-dependent ion channels and lectin receptors in the sarcolemma of frog skeletal muscle.

Authors:  R E Weiss; W M Roberts; W Stühmer; W Almers
Journal:  J Gen Physiol       Date:  1986-06       Impact factor: 4.086

10.  Putative inhibitory effects of chrysotile, crocidolite, and amosite mineral fibers on the more complex surface membrane glycolipids and glycoproteins.

Authors:  H A Newman; Y A Saat; R W Hart
Journal:  Environ Health Perspect       Date:  1980-02       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.